Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy

Trial Profile

Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Apr 2015

At a glance

  • Drugs NPO 13 (Primary)
  • Indications Intestinal disorders
  • Focus Therapeutic Use
  • Sponsors Nihon Pharmaceutical
  • Most Recent Events

    • 14 Apr 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 24 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top